CRIS Current Research Information System

GALVANI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.966
NA - Nord America 1.474
EU - Europa 1.416
AF - Africa 155
Continente sconosciuto - Info sul continente non disponibili 92
SA - Sud America 73
OC - Oceania 1
Totale 5.177
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.416
IT - Italia 770
VN - Vietnam 711
SG - Singapore 424
CN - Cina 360
HK - Hong Kong 141
GB - Regno Unito 131
DE - Germania 119
NL - Olanda 84
BD - Bangladesh 75
FR - Francia 73
BR - Brasile 57
IN - India 51
KR - Corea 48
FI - Finlandia 40
SC - Seychelles 40
CI - Costa d'Avorio 39
CA - Canada 37
SE - Svezia 36
IE - Irlanda 34
JP - Giappone 34
TG - Togo 30
ZA - Sudafrica 28
ES - Italia 22
CH - Svizzera 21
RU - Federazione Russa 20
TH - Thailandia 20
PH - Filippine 18
BG - Bulgaria 16
AT - Austria 13
ID - Indonesia 13
JO - Giordania 13
PL - Polonia 13
PK - Pakistan 12
TR - Turchia 11
MX - Messico 10
TW - Taiwan 10
BE - Belgio 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
CR - Costa Rica 3
EC - Ecuador 3
EG - Egitto 3
HN - Honduras 3
HR - Croazia 3
IQ - Iraq 3
IR - Iran 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
PE - Perù 3
PT - Portogallo 3
UZ - Uzbekistan 3
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
GH - Ghana 2
JM - Giamaica 2
LT - Lituania 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 5.085
Salva come PNG Salva come JPEG
Città #
Singapore 338
Bologna 230
Ho Chi Minh City 195
Ashburn 180
Hanoi 160
San Jose 124
Hong Kong 119
Chandler 106
Hefei 106
Council Bluffs 77
Boardman 69
Dallas 46
Bristol 45
Milan 44
Santa Clara 44
Seoul 43
Fairfield 42
Frankfurt am Main 40
Los Angeles 40
New York 40
Abidjan 39
Helsinki 36
Southend 34
Dublin 33
Lomé 30
Beijing 29
Islington 29
Lauterbourg 29
Redmond 29
Trento 29
Ann Arbor 27
Da Nang 27
Dong Ket 26
Tokyo 25
Haiphong 24
Johannesburg 23
Turin 23
Amsterdam 20
Houston 18
Munich 18
Princeton 18
Modena 17
Rome 17
Chicago 16
Marano 16
Sofia 16
Bern 15
Jerez De La Frontera 15
Amman 13
Argelato 13
San Diego 13
Rimini 12
Buffalo 11
Florence 11
Paris 11
Phoenix 11
Seattle 11
Vienna 11
Wilmington 11
Cambridge 10
Forlì 10
Hải Dương 10
Jakarta 10
Nha Trang 10
Parma 10
São Paulo 10
Woodbridge 10
Bengaluru 9
Berlin 9
Bolzano 9
Montreal 9
Toronto 9
Warsaw 9
Imola 8
Redondo Beach 8
Bangkok 7
Bari 7
Biên Hòa 7
Castel Maggiore 7
Des Moines 7
Long Xuyen 7
Treviso 7
Điện Bàn 7
Can Tho 6
Cesena 6
Medford 6
Orem 6
Palermo 6
Philadelphia 6
Polinago 6
Quận Một 6
Shanghai 6
Shenzhen 6
Brussels 5
Bắc Giang 5
Cao Lanh 5
Changsha 5
Genoa 5
Lahore 5
Naples 5
Totale 3.195
Salva come PNG Salva come JPEG
Nome #
Inhibition of microglia over-activation restores neuronal survival and maturation in a mouse model of CDKL5 deficiency disorder 401
Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death 353
A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder 304
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder 299
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies 293
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder 264
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder 258
CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling (vol 29, pg 658, 2019) 252
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder 246
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 245
Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons 244
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 232
Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist 219
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder 209
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 189
Mir-30e-3p/CXCL3 axis is involved in sorafenib resistance of hepatocellular carcinoma through the modulation of the tumor immune microenvironment 118
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement 111
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients. 95
miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment 82
MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma 80
MiR-22-3p targets the G2/M checkpoint inhibitor Wee1 and represents a possible biomarker of TACE response in hepatocellular carcinoma 80
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma 78
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 77
The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma 74
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. 73
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients. 71
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 64
MiR-22 regulates HIF-1A pathway and tumor progression and represents a possible biomarker of sorafenib response in hepatocellular carcinoma 62
MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to sorafenib Treatment 56
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma 48
Totale 5.177
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.300
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022304 0 18 28 37 20 13 18 18 17 25 62 48
2022/2023589 31 78 36 45 65 56 24 57 95 14 49 39
2023/2024291 9 21 4 29 12 51 42 40 32 12 13 26
2024/2025627 51 64 57 50 45 29 58 29 18 86 61 79
2025/20262.964 205 344 162 129 155 193 395 149 632 161 162 277
2026/2027200 122 78 0 0 0 0 0 0 0 0 0 0
Totale 5.177